All Legal articles
View all stories with this category.
-
BusinessFrance to ban 36 glyphosate products by end of 2020
Move follows similar bans in several European states, with safety agency citing ‘absence of scientific data ruling out genotoxic risks’
-
Opinion
When should employees share profits from inventions?
Glucose monitor inventor wins £2m payout from Unilever after claiming his work provided ’outstanding benefit’
-
Business
Pharmaceuticals roundup 2019
Under the shadow of political turmoil and major lawsuits, the industry returned to its strengths – making new drugs, and finding new ways to do it better
-
Business
Former Braskem chief arrested in US for bribery
Ex-leader of Brazilian petrochemical firm allegedly helped divert $250m to a secret slush fund to bribe government officials and political parties
-
Business
Former Ranbaxy owners arrested for fraud
Singh brothers accused of misappropriation, as well as not paying previous fines relating to Ranbaxy’s takeover by Daiichi Sankyo
-
Opinion
Is bankruptcy best for Purdue?
Many would prefer to see the Sackler family held personally liable, and the company wound down
-
Business
Chemical firms urged to plan for no-deal Brexit
European Chemicals Agency highlights hundreds of chemicals whose Reach registrations would be voided
-
Business
Landmark ruling in Oklahoma opioid lawsuit
J&J judged responsible for ‘public nuisance’ in first case to go to trial
-
Business
US judges slash damages in glyphosate cancer lawsuits
While upholding rulings linking the herbicide to cancer, judges have cut Bayer-Monsanto’s fines from billions to tens of millions of dollars
-
News
Patient and research groups condemn draft bill allowing human gene patenting in US
A measure floated by Congress could hinder research and access to gene tests and raise their costs
-
Opinion
Is Bayer regretting its Monsanto takeover?
Large damages in Roundup litigation have got investors questioning the move
-
Business
Jury awards $2bn damages in US glyphosate trial
Bayer vows to appeal third defeat over Monsanto’s Roundup weedkiller, while experts suggest damages will likely be reduced
-
Business
Emerging from the US opioid crisis
With litigation against suppliers in full swing, how does the US counter its addiction to powerful painkillers?
-
Opinion
Show me the data
Making industrial safety research more transparent benefits both companies and consumers
-
News
Why jury verdicts get overruled in US industry cancer trials
Judges often end up intervening post-trial in complex cases with conflicting scientific evidence
-
Business
DowDuPont ends fungicide dog experiment amid public pressure
Brazil agrees regulatory waiver for ‘unnecessary’ experiment highlighted in US Humane Society undercover footage
-
Opinion
Divergent reality
If the UK leaves the EU without a deal, the two will inevitably drift further apart
-
Business
What might Brexit mean for industry?
Questions hang over regulation, trade, talent and investment
-
Business
US government sued for delaying dichloromethane paint stripper ban
Environmental Protection Agency advances long-awaited ban on consumer products, but allows commercial use to continue
-
Business
Chinese plant closures disrupt supply chains
Environmental clampdown knocks out major suppliers of some ingredients
